A recently identified fusion protein is FGFR3-TACC3, which has been discovered in glioblastoma, lung cancer, bladder cancer, oral cancer, head and neck squamous cell carcinoma, gallbladder cancer, and cervical cancer [2–4]. This evidence concerns the gene FGFR3 and cervical cancer.